UNSPSC 51181629: Levothyroxine sodium

This classification denotes a thyroid hormone with the molecular formula C15H10I4NO4.Na.H2O, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 9J765S329G, chemically known as 3,5,3,5-tetraiodothyronine but more generally known as levothyroxine sodium, which bears U.S. National Institutes of Health Compound Identifier 853. European Medicines Agency schedules Levothyroxine sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08495MIG.

World Health Organization schedules levothyroxine sodium in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary.

UNSPSC 51181629 Levothyroxine sodium is a Commodity code covering the procurement of this synthetic thyroid hormone medication by state and local health agencies, correctional facilities, and public health departments. State and local governments purchase levothyroxine sodium primarily through health-system procurement offices, pharmacy benefit managers, and group purchasing organizations to supply public hospitals, clinics, correctional medical services, and emergency departments. The medication is typically procured in bulk quantities as a generic pharmaceutical and is often bundled within broader RFQs or ITBs for institutional pharmacy supplies or formulary medications.

The source provided contains no recent state and local contract opportunities tagged to this code, preventing characterization of current geographic activity, issuing-body concentration, or representative recent solicitations.